ZA949798B - Long-acting injection suspensions and a process for their preparation. - Google Patents

Long-acting injection suspensions and a process for their preparation.

Info

Publication number
ZA949798B
ZA949798B ZA949798A ZA949798A ZA949798B ZA 949798 B ZA949798 B ZA 949798B ZA 949798 A ZA949798 A ZA 949798A ZA 949798 A ZA949798 A ZA 949798A ZA 949798 B ZA949798 B ZA 949798B
Authority
ZA
South Africa
Prior art keywords
preparation
long
injection suspensions
acting injection
acting
Prior art date
Application number
ZA949798A
Other languages
English (en)
Inventor
Juergen Engel
Karin Klokkers-Bethke
Thomas Reissmann
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ZA949798B publication Critical patent/ZA949798B/xx
Priority claimed from US08/661,017 external-priority patent/US5773032A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA949798A 1993-12-09 1994-12-08 Long-acting injection suspensions and a process for their preparation. ZA949798B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (de) 1993-12-09 1993-12-09 Langwirkende Injektionssuspension und Verfahren zur Herstellung
US08/661,017 US5773032A (en) 1993-12-09 1996-06-10 Long-acting injection suspensions and a process for their preparation

Publications (1)

Publication Number Publication Date
ZA949798B true ZA949798B (en) 1995-08-18

Family

ID=25931926

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949798A ZA949798B (en) 1993-12-09 1994-12-08 Long-acting injection suspensions and a process for their preparation.

Country Status (27)

Country Link
EP (1) EP0732934B1 (xx)
JP (1) JPH09509145A (xx)
CN (2) CN1248732C (xx)
AT (1) ATE310530T1 (xx)
AU (1) AU677748B2 (xx)
BR (1) BR9408272A (xx)
CZ (1) CZ291025B6 (xx)
DE (1) DE4342092B4 (xx)
DK (1) DK0732934T3 (xx)
EE (1) EE03224B1 (xx)
EG (1) EG20787A (xx)
ES (1) ES2251715T3 (xx)
FI (1) FI116121B (xx)
HK (1) HK1063746A1 (xx)
HR (1) HRP940978B1 (xx)
HU (1) HU217081B (xx)
IL (1) IL111928A (xx)
LV (1) LV11596B (xx)
NO (1) NO318984B1 (xx)
NZ (1) NZ277239A (xx)
PL (1) PL186929B1 (xx)
RO (1) RO119343B1 (xx)
RS (1) RS49511B (xx)
RU (1) RU2152222C1 (xx)
SK (2) SK284981B6 (xx)
WO (1) WO1995015767A1 (xx)
ZA (1) ZA949798B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
UA44722C2 (uk) * 1993-12-09 2002-03-15 Аста Медіка Акціенгезельшафт Лікарський засіб пролонгованої дії для зниження рівня тестостерону
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
TWI332407B (en) 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CN101563068B (zh) 2006-12-18 2013-03-20 武田药品工业株式会社 缓释组合物和其制备方法
RU2548753C2 (ru) 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
CN102504018A (zh) * 2011-10-28 2012-06-20 沈阳药科大学 可持续释放的蜂毒肽帕莫酸盐及其制剂
WO2017167180A1 (zh) * 2016-03-29 2017-10-05 上海华汇拓医药科技有限公司 沃替西汀的帕莫酸盐及其晶型
CN108969478A (zh) * 2018-08-29 2018-12-11 江南大学 一种美金刚难溶盐缓释注射剂及其制备方法
CN110003195B (zh) * 2019-05-21 2020-05-26 湖北中医药大学 鲁拉西酮晶体及其制备方法和在注射给药系统中的应用
CN112569340A (zh) * 2020-12-31 2021-03-30 苏州素仕生物科技有限公司 一种无菌布舍瑞林注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
CH679207A5 (xx) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
PL186929B1 (pl) 2004-04-30
DE4342092B4 (de) 2007-01-11
EP0732934A1 (en) 1996-09-25
EG20787A (en) 2000-02-29
SK284980B6 (sk) 2006-03-02
CN1136916C (zh) 2004-02-04
WO1995015767A1 (en) 1995-06-15
ES2251715T3 (es) 2006-05-01
NO961877L (no) 1996-05-09
HRP940978B1 (en) 2006-08-31
CZ142096A3 (en) 1996-12-11
DE4342092A1 (de) 1995-06-14
DK0732934T3 (da) 2006-03-27
NZ277239A (en) 1997-03-24
RS49511B (sr) 2006-10-27
LV11596A (lv) 1996-12-20
HU9601584D0 (en) 1996-08-28
RO119343B1 (ro) 2004-08-30
JPH09509145A (ja) 1997-09-16
AU1219995A (en) 1995-06-27
FI116121B (fi) 2005-09-30
AU677748B2 (en) 1997-05-01
HU217081B (hu) 1999-11-29
IL111928A (en) 1999-11-30
CN1494919A (zh) 2004-05-12
NO961877D0 (no) 1996-05-09
NO318984B1 (no) 2005-05-30
CN1136779A (zh) 1996-11-27
SK284981B6 (sk) 2006-03-02
CN1248732C (zh) 2006-04-05
FI962354A0 (fi) 1996-06-06
SK66796A3 (en) 1997-08-06
EE03224B1 (et) 1999-10-15
EP0732934B1 (en) 2005-11-23
RU2152222C1 (ru) 2000-07-10
HRP940978A2 (en) 1997-02-28
CZ291025B6 (cs) 2002-12-11
YU72194A (sh) 1997-03-07
IL111928A0 (en) 1995-03-15
PL314913A1 (en) 1996-09-30
BR9408272A (pt) 1996-12-17
ATE310530T1 (de) 2005-12-15
HK1063746A1 (en) 2005-01-14
HUT75712A (en) 1997-05-28
LV11596B (en) 1997-06-20
FI962354A (fi) 1996-06-06

Similar Documents

Publication Publication Date Title
HK1063746A1 (en) Long-acting injection suspensions and a process for their preparation
CA2178592A1 (en) Long-acting injection suspensions and a process for their preparation
BG101781A (en) Active substance-containing solid preparation
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
EP2016950A8 (en) Pharmaceutical composition comprising an exendin-4 peptide
AU8418891A (en) Novel polyamines and method for preparation thereof
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
CA2135062A1 (en) Pharmaceutical and Other Dosage Forms
CA2203033A1 (en) Compounds and compositions for delivering active agents
IL106693A (en) Controlled sustained release tablets containing bupropion hydrochloride
CA2354034A1 (en) Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
GR3026338T3 (en) High release solid preparation, preparation and use thereof
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
ES2013129A6 (es) Procedimiento de obtencion de una composicion farmaceutica a base de n-metil-n- (1-fenil -2- propil) -2- propinilamina.
TW370532B (en) The use of cetrorelix and other nona and decapeptides in the preparation of a medicament for combating AIDS and for growth stimulation
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
CA2273272A1 (en) Immediate release drug delivery forms
MX9804120A (es) Nuevos antagonistas de la lh-rh con efectividad mejorada.
MY105110A (en) Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
GB2279871B (en) Drug retention systems for use in aquaculture
CA2021282A1 (en) Dispenser comprising ionophore
AU5886390A (en) Pharmaceutically active derivative delivery systems